These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31282378)

  • 1. Candida species isolated from pigeon (Columbia livia) droppings may express virulence factors and resistance to azoles.
    Magalhães Pinto L; de Assis Bezerra Neto F; Araújo Paulo de Medeiros M; Zuza Alves DL; Maranhão Chaves G
    Vet Microbiol; 2019 Aug; 235():43-52. PubMed ID: 31282378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity, Virulence Factors, and Antifungal Susceptibility Patterns of Pathogenic and Opportunistic Yeast Species in Rock Pigeon (
    Abulreesh HH; Organji SR; Elbanna K; Osman GEH; Almalki MHK; Abdel-Malek AY; Ghyathuddin AAK; Ahmad I
    Pol J Microbiol; 2019 Dec; 68(4):493-504. PubMed ID: 31880893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil.
    Costa AK; Sidrim JJ; Cordeiro RA; Brilhante RS; Monteiro AJ; Rocha MF
    Mycopathologia; 2010 Mar; 169(3):207-13. PubMed ID: 19847668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health.
    Brilhante RSN; de Alencar LP; Cordeiro RA; Castelo-Branco DSCM; Teixeira CEC; Macedo RB; Lima DT; Paiva MAN; Monteiro AJ; Alves ND; Franco de Oliveira M; Sidrim JJC; Rocha MFG; Bandeira TJPG; Rodrigues TJS
    J Med Microbiol; 2013 Jun; 62(Pt 6):889-895. PubMed ID: 23493027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity.
    Sidrim JJ; Maia DC; Brilhante RS; Soares GD; Cordeiro RA; Monteiro AJ; Rocha MF
    Vet Microbiol; 2010 Oct; 145(3-4):324-8. PubMed ID: 20493645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida tropicalis isolates obtained from veterinary sources show resistance to azoles and produce virulence factors.
    Cordeiro Rde A; de Oliveira JS; Castelo-Branco Dde S; Teixeira CE; Marques FJ; Bittencourt PV; Carvalho VL; Bandeira Tde J; Brilhante RS; Moreira JL; Pereira-Neto Wde A; Sidrim JJ; Rocha MF
    Med Mycol; 2015 Feb; 53(2):145-52. PubMed ID: 25550392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.
    Moreira A; Silva S; Botelho C; Sampaio P; Pais C; Henriques M
    Mycopathologia; 2015 Dec; 180(5-6):305-15. PubMed ID: 26179982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeasts from Scarlet ibises (Eudocimus ruber): A focus on monitoring the antifungal susceptibility of Candida famata and closely related species.
    Brilhante RSN; Silva ALD; Monteiro FOB; Guedes GMM; Sales JA; Oliveira JS; Maia Junior JE; Miranda SA; Sidrim JJC; Alencar LP; Castelo-Branco DSCM; Cordeiro RA; Pereira Neto WA; Rocha MFG
    Med Mycol; 2017 Oct; 55(7):725-732. PubMed ID: 28204651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
    Passos XS; Costa CR; Araújo CR; Nascimento ES; e Souza LK; Fernandes Ode F; Sales WS; Silva Mdo R
    Mycopathologia; 2007 Mar; 163(3):145-51. PubMed ID: 17334813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FREQUENCY OF Candida SPECIES IN A TERTIARY CARE HOSPITAL IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL.
    Menezes Rde P; Ferreira JC; de Sá WM; Moreira Tde A; Malvino LD; de Araujo LB; Röder DV; Penatti MP; Candido RC; Pedroso Rdos S
    Rev Inst Med Trop Sao Paulo; 2015; 57(3):185-91. PubMed ID: 26200956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.